Kinase fusions are frequent in Spitz tumours and spitzoid melanomas-Reference-Cited by-同舟云学术

Kinase fusions are frequent in Spitz tumours and spitzoid melanomas

Published:2014-01-20 Issue:1 Volume:5 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Wiesner Thomas,He Jie,Yelensky Roman,Esteve-Puig Rosaura,Botton Thomas,Yeh Iwei,Lipson Doron,Otto Geoff,Brennan Kristina,Murali Rajmohan,Garrido Maria,Miller Vincent A.,Ross Jeffrey S.,Berger Michael F.,Sparatta Alyssa,Palmedo Gabriele,Cerroni Lorenzo,Busam Klaus J.,Kutzner Heinz,Cronin Maureen T.,Stephens Philip J.,Bastian Boris C.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms4116.pdf

Reference44 articles.

1. Spitz, S. Melanomas of childhood. Am. J. Pathol. 24, 591–609 (1948).

2. Ludgate, M. W. et al. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer 115, 631–641 (2009).

3. Murali, R. et al. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors). Ann. Surg. Oncol. 15, 302–309 (2008).

4. Flaherty, K. T., Hodi, F. S. & Fisher, D. E. From genes to drugs: targeted strategies for melanoma. Nat. Rev. Cancer 12, 349–361 (2012).

5. Bastian, B. C., LeBoit, P. E. & Pinkel, D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am. J. Pathol. 157, 967–972 (2000).

Cited by 532 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond;Critical Reviews in Oncology/Hematology;2024-09

2. NRAS^Q61R‐driven atypical melanocytic tumor with blue nevus‐like morphology: A case report;Journal of Cutaneous Pathology;2024-08-23

3. Histopathologic, genomic, transcriptomic, and functional characteristics of eight melanocytic tumors with BRAF fusions showing stronger MAPK pathway activation compared to BRAF V600E tumors;Journal of Cutaneous Pathology;2024-08-22

4. The Clinical, Morphologic, and Molecular Spectrum of BRAF Fusion Spitz Tumors;American Journal of Surgical Pathology;2024-08-22

5. Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-21